GRC SinoGreen Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
13
- Investments
-
57
- Portfolio
-
28
- Exits
-
15
GRC SinoGreen Fund General Information
Company Description
Founded in 2005, Grand River Capital Management is a venture capital firm based in Shenzhen, China. The firm seeks to invest in the energy, resource efficiency, and healthcare industry innovation sectors.
Business Details
Website
www.grcfunds.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Room 08A, 37A Floor, Building 4, Excellence Century Center
- Number 3037 Jintian Road, Fuan Community, Futian District
- Shenzhen, Guangdong
- China
GRC SinoGreen Fund Investments (57)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| PAM2L Biotechnologies | 22-Oct-2026 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Seal (China) | 09-Oct-2026 | Software Development Applications | Generating Revenue | |||
| Rongxin Zhiyuan | 07-May-2026 | Application Specific Semiconductors | Generating Revenue | |||
| PAM2L Biotechnologies | 20-Apr-2026 | Drug Discovery | Generating Revenue | |||
| Weihai Smart Chip | 02-Apr-2026 | Application Specific Semiconductors | Generating Revenue | |||
| MetaNovas Biotech | 09-Mar-2026 | Biotechnology | Generating Revenue | |||
| Zhiyuan Craftsmanship | 11-Dec-2025 | Application Specific Semiconductors | Generating Revenue | |||
| Meta Silicon | 03-Nov-2025 | Production (Semiconductors) | Generating Revenue | |||
| PAM2L Biotechnologies | 03-Nov-2025 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Interposer | 30-Sep-2025 | Early Stage VC | Other Semiconductors | Generating Revenue |
GRC SinoGreen Fund Exits (15)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Avertana | 01-Mar-2026 | Secondary Transaction - Private | |
| Googol Technology (HK) | 14-Aug-2023 | ||
| Heal (Clinics/Outpatient Services) | 01-Jan-2023 | ||
| Apexigen | 01-Aug-2022 | ||
| Centrillion Technologies | 30-May-2022 | ||
| Cepton | 11-Feb-2022 | ||
| Rancher Labs | 26-Nov-2020 | ||
| CNano | 15-Jul-2019 | ||
| S2C | 31-Oct-2018 | Merger/Acquisition | |
| All Cosmos Bio-Tech Hldg | 30-Sep-2017 | IPO |
GRC SinoGreen Fund Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
GRC SinoGreen Fund Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
GRC SinoGreen Fund Co-Investors (92)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Addor Capital | 2 |
|
|
||
| CTC Capital |
|
|
|||
| Legend Capital |
|
|
|||
| SAIF Partners |
|
|
|||
| Yunqi Partners |
|
|
GRC SinoGreen Fund FAQs
-
What is GRC SinoGreen Fund?
Founded in 2005, Grand River Capital Management is a venture capital firm based in Shenzhen, China.
-
When was GRC SinoGreen Fund founded?
GRC SinoGreen Fund was founded in 2005.
-
Where is GRC SinoGreen Fund headquartered?
GRC SinoGreen Fund is headquartered in Shenzhen, China.
-
What is GRC SinoGreen Fund's total asset value?
GRC SinoGreen Fund has around in total assets under management.
-
How many investments has GRC SinoGreen Fund made?
GRC SinoGreen Fund has made 57 investments.
-
What has GRC SinoGreen Fund invested in?
GRC SinoGreen Fund has made numerous investments in companies like PAM2L Biotechnologies, Seal (China), and Rongxin Zhiyuan within the Drug Discovery, Software Development Applications, and Application Specific Semiconductors industries.
-
What has GRC SinoGreen Fund invested in recently?
GRC SinoGreen Fund's latest investment was on 22-Oct-2026 in PAM2L Biotechnologies, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
